Edgewood, KYNCT07102160Now EnrollingIRB Ready

Deep Vein Thrombosis (DVT) Clinical Trial in Edgewood, KY

Access cutting-edge deep vein thrombosis (dvt) treatment through this clinical trial at a research site in Edgewood. Study-provided care at no cost to qualified participants.

Sponsored by Argon Medical Devices

Quick Self-Assessment

See if you qualify for this Edgewood location

Preparing your pre-screening questions…

Expert Care in Edgewood

Access deep vein thrombosis (dvt) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related deep vein thrombosis (dvt) treatment provided free

Apply for This Edgewood Location

Check if you qualify for this deep vein thrombosis (dvt) clinical trial in Edgewood, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Edgewood

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Edgewood site if eligible
  4. 4Begin participation

About This Deep Vein Thrombosis (DVT) Study in Edgewood

The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac® Thrombectomy System for the treatment of thrombus in patients with lower extremity proximal deep vein thrombosis (DVT). This prospective, multi-center, open-label study will assess clinical outcomes, device performance, and procedural success in a single DVT study cohort.

Sponsor: Argon Medical Devices

Who Can Participate

Inclusion Criteria

Participants must meet all the following criteria to be eligible for the study:
At least 18 years of age at the time of consent.
Undergo frontline (primary) treatment with Cleaner Vac® Thrombectomy System in the peripheral venous vasculature and have at least one component introduced into the body.
Written informed consent obtained through the IRB-approved ICF. For the DVT cohort, participants must meet all criteria above and below to be eligible for the study:
Present with unilateral or bilateral lower extremity DVT involving at least one of the following veins:
Femoral-popliteal vein
Common femoral vein
Inferior Vena Cava (IVC)
DVT diagnosis confirmed by imaging within 14 days of the index procedure.
Symptomatic DVT with onset within 6 weeks of enrollment.

Exclusion Criteria

Subjects will be excluded from the study if any of the following criteria are met:
Contraindication to systemic or therapeutic doses of anticoagulants.
Contraindication to iodinated contrast that cannot be adequately premedicated.
Life expectancy less than 1 year due to advanced malignancy, as determined by the investigator at the time of enrollment
Patients that are pregnant.
Known coagulation disorders both acquired (Heparin Induced Thrombocytopenia, etc.) or genetic (e.g., Factor V Leiden, etc.), thrombophilia, or hypercoagulable states that, in the opinion of the Investigator, cannot be medically managed throughout the study period.
Treatment of target venous segment with thrombolytics within previous 14 days of the index procedure.
Known congenital anatomic anomalies of the inferior vena cava (IVC) or iliac veins.
Known history of a Patent Foramen Ovale (PFO).
Hemoglobin \< 8.0 g/dL, INR \> 2.0 before warfarin was started, or platelets \< 50,000/µl which cannot be corrected prior to enrollment.
Severe renal impairment (estimated GFR \< 30 ml/min) in patients who are not yet on dialysis. Patients with GFR \<30 ml/min who are already on dialysis can be enrolled.
Patients with intermediate-high risk or high-risk pulmonary embolism (PE) defined as follows:
High-risk PE: Presence of hemodynamic instability, including cardiac arrest, obstructive shock (systolic blood pressure \<90 mmHg or need for vasopressors with signs of end-organ hypoperfusion), or persistent hypotension (systolic BP \<90 mmHg or a drop ≥40 mmHg for \>15 minutes not due to other causes)
Intermediate-high-risk PE: Hemodynamically stable patients with both right ventricular (RV) dysfunction (on echocardiography or CT) and elevated cardiac biomarkers (e.g., troponin).
Complete infrarenal IVC occlusion.
Chronic non-ambulatory status.
Current enrollment in another investigational device or drug study that may confound the results of this study. Studies requiring extended follow-up for products that were investigational but have since become commercially available are not considered investigational studies.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Edgewood?

Yes, this clinical trial (NCT07102160) has an active research site in Edgewood, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Deep Vein Thrombosis (DVT) Treatment Options in Edgewood, KY

If you're searching for deep vein thrombosis (dvt) treatment options in Edgewood, KY, this clinical trial (NCT07102160) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Edgewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced deep vein thrombosis (dvt) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all deep vein thrombosis (dvt) clinical trials near you to find additional studies recruiting in your area.

More Deep Vein Thrombosis Trials in Edgewood, KY

See all deep vein thrombosis clinical trials recruiting in Edgewood — not just this study.

Browse Deep Vein Thrombosis Trials in Edgewood →

Browse More Trials by Condition

Deep Vein Thrombosis TrialsVenous Thromboembolism TrialsAll Conditions →

Ready to Join in Edgewood?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Edgewood, KY